NeuroPace (NPCE) Work In Process (2020 - 2026)
NeuroPace's (NPCE) quarterly Work In Process came in at $4.4 million in Q1 2026, up 105.68% year-on-year from $2.1 million in Q1 2025, and up 57.63% quarter-over-quarter from $2.8 million in Q4 2025.
NeuroPace (NPCE) Work In Process (2020 - 2026) Analysis & Trends
NeuroPace's Work In Process history runs 7 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- On a quarterly basis, Work In Process rose 105.68% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 105.68% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 28.97% from the prior year.
- Work In Process advanced to $4.4 million in Q1 2026 per NPCE's latest filing, from $2.8 million in the prior quarter.
- Across five years, Work In Process topped out at $4.4 million in Q1 2026 and bottomed at $501000.0 in Q3 2022.
- The 5-year median for Work In Process is $1.5 million (2024), against an average of $1.6 million.
- Across the five-year window, Work In Process plunged 65.85% in 2022 and jumped 243.54% in 2024, its largest moves.
- Year by year, Work In Process stood at $1.5 million in 2022, then slumped by 58.83% to $627000.0 in 2023, then soared by 243.54% to $2.2 million in 2024, then increased by 28.97% to $2.8 million in 2025, then soared by 57.63% to $4.4 million in 2026.
- Per Business Quant, the three latest NPCE Work In Process figures stand at $4.4 million (Q1 2026), $2.8 million (Q4 2025), and $2.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | NeuroPace | 517.05 Mn | 463.07 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.38 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | 2.35 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 627,000.00 |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 789,000.00 |
| Mar 31, 2023 | 592,000.00 |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 501,000.00 |
| Jun 30, 2022 | 747,000.00 |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 879,000.00 |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 1.29 Mn |